Principal Investigator
Terrence Bradley
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250682
Clinical Trial Summary
A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)
Phase
Phase II
Funding Agency/Sponsor
National Cooperative Group
Disease
Leukemia
Contact Information
Phone Number
+1 (305) 2437261